GSMA
24.5.2018 09:02:11 CEST | Business Wire | Press release
The GSMA today provided further details on the array of events and programmes that will be available to attendees at the 2018 GSMA Mobile World Congress Shanghai, including partner and co-located events; GSMA Forums, Seminars and Workshops; and Partner Programmes. Mobile World Congress Shanghai will be held 27-29 June at the Shanghai New International Expo Centre (SNIEC).
“We’ve expanded the number of programmes and events at Mobile World Congress Shanghai, featuring everything from sports and fitness to service robots to the intersection of art and innovation, and beyond,” said Michael O’Hara, Chief Marketing Officer, GSMA. “We have a very exciting event lined up and we are looking forward to bringing the mobile world together in Shanghai next month.”
New Details on Partner and Co-located Events at Mobile World Congress Shanghai
The GSMA today provided an update on the partner and co-located events that will be held concurrently with Mobile World Congress Shanghai, offering attendees a wide range of experiences.
Migu Health and Fitness Festival
Held 27-29 June in Hall W4 at the SNIEC, the Migu Health and Fitness Festival comprises a broad set of sports programmes and activities, all with a technology connection. Among the activities is the Charity Walk Challenge, in which the China Mobile Charity Foundation will donate funds matching the number of kilometres walked by Challenge participants. The donations will be used to aid students from impoverished areas in China. For more information on the Migu Health and Fitness Festival, visit: www.mwcshanghai.com/experiences/migu-health-fitness-festival/ .
2018 Shanghai International Service Robot Show
The 2018 Shanghai International Service Robot Show will be held concurrently with Mobile World Congress Shanghai at the SNIEC in Hall N1. Established in 2015, the event is hosted by the China Service Robotics Industry Alliance and Caiqi Culture Communication (Shanghai) Co. Ltd. and co-organised by the Robotics Industry Technology Innovation Strategic Alliance of Ministry of Science and Technology. The event will demonstrate applications of service robots across a range of industries. The China International Child Intelligent Technology and Educational Robot Show will also take place in the same venue. For more information about the two shows, visit: www.en.srshow.cn .
Display China 2018
Display China will be co-located with Mobile World Congress Shanghai 27-29 June at the SNIEC. Mobile World Congress Shanghai attendees holding VIP, Gold, All Exhibition or Press/Analyst Passes will have access to Display China 2018. For more information about Display China, visit: http://en.srshow.cn .
New Exhibitors, Sponsors Confirmed for MWC Shanghai Show Floor
The first S-Nova Award will be presented during Mobile World Congress Shanghai, with finalists showcased at the SNIEC. Established by Association Des Jeunes Artistes Franco-Chinois (AJAFC), the S-Nova Award is a global award that recognises innovation at the intersection of art and technology fields and seeks to create business opportunities in these areas. The shortlisted entries for the Award will be showcased at stand D01 in Hall N5 during the event. For more information about the Award, visit: www.mwcshanghai.com/experiences/s-nova-award/ .
Newly confirmed exhibitors and sponsors for Mobile World Congress Shanghai include Ant Finance, AT&T, Canalys, Lenovo, PwC, Synchronoss, Tata Communications and Vodafone, among others. For more information on the exhibition, visit www.mwcshanghai.com/exhibition/2018-exhibitors/ .
GSMA Forums, Seminars and Workshops
The GSMA will host a number of forums, seminars and workshops at Mobile World Congress Shanghai to share the latest developments in key industry programmes and advocacy initiatives. Currently scheduled GSMA programmes include:
- Industrial Internet Workshop, organised by the GSMA and Alliance of Industrial Internet (Wednesday, 27 June, NEXTech Theatre, Hall W5, SNIEC)
- 3rd Annual 5G Spectrum and Policy Workshop (Thursday, 28 June, Jumeirah Hotel)
- Future Broadband Forum, organised by the GSMA and C114, sponsored by Hengtong, Nokia and Zhongtian (Thursday, 28 June, Kerry Hotel)
- Data Protection and Privacy Policy Workshop (Thursday, 28 June, Jumeirah Hotel)
- eSIM Workshop (Friday, 29 June, Hall N5-M50, SNIEC)
For more information on GSMA Forums, Seminars and Workshops, visit: www.mwcshanghai.com/conference-programmes/forums-seminars/ .
New Partner Programmes in Shanghai
Mobile World Congress Shanghai will feature a range of partner programmes developed by leading players from across the mobile ecosystem. The 42nd Asia Pacific Mobile Operators Conference, sponsored by CLX Communications, MessageBird, SAP Asia, Syniverse Technologies and WIT Software, will be held on Monday, 25 June at the Kerry Hotel. Huawei will host six events from Tuesday, 26 June through Thursday, 28 June, while China Unicom will host its partner programme on Tuesday, 26 June. The GTI Summit Shanghai 2018 will take place on Wednesday, 27 June and Tata Communications will also run a workshop on that date. On Thursday, 28 June, the 5G Automotive Association and Vodafone will each host events. For more information about the Partner Programmes, visit: www.mwcshanghai.com/conference-programmes/partner-programmes/ .
Get Involved at Mobile World Congress Shanghai 2018
For more information on Mobile World Congress Shanghai, including how to attend, exhibit, partner or sponsor, visit www.mwcshanghai.com . Follow developments and updates on Mobile World Congress Shanghai through our social media channels – follow us on Twitter at @GSMA and use #MWCS18, get regular updates through our LinkedIn Showcase Page at www.linkedin.com/company/mobile-world-congress-shanghai , and follow us on Facebook at www.facebook.com/mwcshanghai . In China, you can follow us on Sina Weibo weibo.com/mwcshanghai or search “GSMA_MWCS” in WeChat.
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting nearly 800 operators with more than 300 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces industry-leading events such as Mobile World Congress, Mobile World Congress Shanghai, Mobile World Congress Americas and the Mobile 360 Series of conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180524005434/en/
Contact:
GSMA
Media Contacts:
For the GSMA
Ava Lau
+852
2533 9928
alau@webershandwick.com
or
Beau
Bass
+44 79 7662 4962
beau.bass@webershandwick.com
or
GSMA
Press Office
pressoffice@gsma.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom